podophyllotoxin has been researched along with Leukemia P388 in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (31.58) | 18.7374 |
| 1990's | 11 (57.89) | 18.2507 |
| 2000's | 2 (10.53) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chu, DT; Clement, JJ; Klein, LL; McDonald, EJ; Plattner, JJ; Yeung, CM | 1 |
| Jurd, L; Narayanan, VL; Paull, KD | 1 |
| Chai, H; Cruz, JG; Hernández, L; Mar, W; Novelo, M; Pereda-Miranda, R; Pezzuto, JM | 1 |
| Chang, JJ; Hamel, E; Juang, JP; Kuo, SC; Lednicer, D; Lee, HZ; Lin, CM; Lin, YT; Paull, KD; Wu, TS | 1 |
| Daley, L; Demerseman, P; Etiévant, C; Guminski, Y; Hill, BT; Imbert, T; Kruczynski, A; Monneret, C | 1 |
| Baasner, S; Böhm, KJ; Gerlach, M; Günther, EG; Müller, K; Prinz, H; Schmidt, P; Unger, E; Zuse, A | 1 |
| Arimondo, PB; Bertounesque, E; Dauzonne, D; Duca, M; Guianvarc'h, D; Kraus-Berthier, L; Léonce, S; Meresse, P; Monneret, C; Pfeiffer, B; Pierré, A; Renard, P; Thirot, S | 1 |
| Hall, IH; Lee, KH; Levy, RK | 1 |
| Alberts, DS; Dorr, RT | 1 |
| Fujimoto, K; Kobunai, T; Nomura, M; Shibata, J; Sugimoto, Y; Terada, T; Wierzba, K; Yamada, Y; Yamashita, J; Yamazaki, R | 1 |
| Anyanwutaku, IO; Chen, HX; Cheng, YC; Guo, X; Ji, Z; Lee, KH | 1 |
| Choe, YH; Conover, CD; Greenwald, RB; Guan, S; Martinez, A; Pendri, A; Shum, KL; Wu, D; Yao, Z | 1 |
| Chen, YZ; Pan, JL; Wang, YG | 1 |
| Fujimoto, K; Kobunai, T; Nomura, M; Takeda, S; Terada, T; Wierzba, K; Yamada, Y; Yamaguchi, H; Yamashita, J | 1 |
| Bugat, R; Canal, P; Chatelut, E; Chevreau, C; de Forni, M; Houin, G; Johnson, NP; Plusquellec, Y; Roche, H | 1 |
| Iwabuchi, M; Takahashi, K | 1 |
| Murray, SL; Slater, LM; Stupecky, M; Sweet, P; Wetzel, MW | 1 |
| Inaba, M | 1 |
| Fairchild, C; Gottlieb, HE; Nudelman, A; Ruse, M | 1 |
1 trial(s) available for podophyllotoxin and Leukemia P388
| Article | Year |
|---|---|
Teniposide and cisplatin given by intraperitoneal administration: preclinical and phase I/pharmacokinetic studies.
Topics: Adult; Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Evaluation; Drug Synergism; Etoposide; Female; Humans; Injections, Intraperitoneal; Leukemia P388; Leukopenia; Male; Mice; Middle Aged; Peritoneal Neoplasms; Podophyllotoxin; Remission Induction; Teniposide | 1991 |
18 other study(ies) available for podophyllotoxin and Leukemia P388
| Article | Year |
|---|---|
Synthesis and antitumor activity of structural analogues of the epipodophyllotoxins.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Carcinoma; Chemical Phenomena; Chemistry; Colonic Neoplasms; Etoposide; Humans; Indans; Leukemia P388; Lung Neoplasms; Mice; Molecular Structure; Podophyllotoxin; Structure-Activity Relationship; Tumor Cells, Cultured | 1991 |
In vivo antitumor activity of 6-benzyl-1,3-benzodioxole derivatives against the P388, L1210, B16, and M5076 murine models.
Topics: Animals; Antineoplastic Agents; Astrocytoma; Bucladesine; Cell Differentiation; Dioxoles; DNA Topoisomerases, Type I; Leukemia L1210; Leukemia P388; Leukemia, Experimental; Mice; Tubulin | 1987 |
Cytotoxic constituents from Hyptis verticillata.
Topics: Animals; Antineoplastic Agents, Phytogenic; Artemia; Candida albicans; Drug Screening Assays, Antitumor; Humans; Leukemia P388; Mexico; Mice; Microbial Sensitivity Tests; Plants, Medicinal; Podophyllotoxin; Rats | 1993 |
Synthesis and cytotoxicity of 1,6,7,8-substituted 2-(4'-substituted phenyl)-4-quinolones and related compounds: identification as antimitotic agents interacting with tubulin.
Topics: Animals; Antineoplastic Agents; Humans; Intestinal Neoplasms; Leukemia L1210; Leukemia P388; Lung Neoplasms; Melanoma; Mice; Molecular Structure; Nasopharyngeal Neoplasms; Quinolines; Quinolones; Software; Structure-Activity Relationship; Tubulin; Tubulin Modulators; Tumor Cells, Cultured | 1993 |
Synthesis and antitumor activity of new glycosides of epipodophyllotoxin, analogues of etoposide, and NK 611.
Topics: Animals; Antineoplastic Agents; Biopolymers; Drug Screening Assays, Antitumor; Female; Glycosides; Glycosylation; Humans; Inhibitory Concentration 50; Leukemia L1210; Leukemia P388; Mice; Mice, Inbred DBA; Podophyllotoxin; Stereoisomerism; Structure-Activity Relationship; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Transplantation, Heterologous; Tubulin; Tumor Cells, Cultured | 1998 |
9-Benzylidene-naphtho[2,3-b]thiophen-4-ones as novel antimicrotubule agents-synthesis, antiproliferative activity, and inhibition of tubulin polymerization.
Topics: Animals; Antineoplastic Agents; Cell Cycle; Cell Proliferation; Cell Survival; Colchicine; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Flow Cytometry; Humans; Inhibitory Concentration 50; K562 Cells; Leukemia P388; Mice; Molecular Structure; Structure-Activity Relationship; Thiophenes; Tubulin; Tubulin Modulators; Tumor Cells, Cultured | 2006 |
Synthesis and biological study of a new series of 4'-demethylepipodophyllotoxin derivatives.
Topics: Animals; Antineoplastic Agents; Carbamates; Cell Line, Tumor; Drug Screening Assays, Antitumor; Humans; Lactones; Leukemia P388; Mice; Podophyllotoxin; Structure-Activity Relationship; Topoisomerase II Inhibitors; Transplantation, Heterologous | 2005 |
Antitumor agents LXII: synthesis and biological evaluation of podophyllotoxin esters and related derivatives.
Topics: Animals; Leukemia P388; Male; Mice; Mice, Inbred Strains; Podophyllotoxin; Structure-Activity Relationship | 1983 |
Skin ulceration potential without therapeutic anticancer activity for epipodophyllotoxin commercial diluents.
Topics: Adenocarcinoma; Animals; Cell Survival; Colonic Neoplasms; Etoposide; Humans; Leukemia P388; Leukemia, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Podophyllotoxin; Skin Ulcer; Solvents; Teniposide; Tumor Stem Cell Assay | 1983 |
Antitumor agents. 3. Synthesis and biological activity of 4 beta-alkyl derivatives containing hydroxy, amino, and amido groups of 4'-O-demethyl-4-desoxypodophyllotoxin as antitumor agents.
Topics: Animals; Antineoplastic Agents; Etoposide; Humans; Leukemia L1210; Leukemia P388; Lung Neoplasms; Molecular Structure; Podophyllotoxin; Structure-Activity Relationship; Topoisomerase II Inhibitors; Tubulin Modulators; Tumor Cells, Cultured | 1993 |
Activities of novel nonglycosidic epipodophyllotoxins in etoposide-sensitive and -resistant variants of human KB cells, P-388 cells, and in vivo multidrug-resistant murine leukemia cells.
Topics: Animals; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; DNA Damage; Drug Resistance, Multiple; Etoposide; Female; Humans; KB Cells; Leukemia P388; Leukemia, Experimental; Mice; Podophyllotoxin; Topoisomerase II Inhibitors | 1996 |
Drug delivery of anticancer agents: water soluble 4-poly (ethylene glycol) derivatives of the lignan, podophyllotoxin.
Topics: Animals; Antineoplastic Agents, Phytogenic; Drug Carriers; Drug Screening Assays, Antitumor; Female; Humans; Inhibitory Concentration 50; Leukemia P388; Lung Neoplasms; Mice; Mice, Nude; Neoplasm Transplantation; Nuclear Magnetic Resonance, Biomolecular; Podophyllotoxin; Polyethylene Glycols; Solubility; Transplantation, Heterologous; Tumor Cells, Cultured; Water | 1999 |
[Synthesis of epipodophyllotoxin carboxylates and antitumor activity in vitro].
Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Hepatocellular; Humans; Leukemia P388; Liver Neoplasms; Mice; Molecular Structure; Podophyllotoxin; Stomach Neoplasms; Tumor Cells, Cultured | 1997 |
Antitumor agents. I. DNA topoisomerase II inhibitory activity and the structural relationship of podophyllotoxin derivatives as antitumor agents.
Topics: Animals; Antineoplastic Agents; Leukemia P388; Mice; Podophyllotoxin; Sarcoma, Experimental; Structure-Activity Relationship; Topoisomerase II Inhibitors | 1992 |
[Kinetics of etoposide cytotoxicity against mouse P388 leukemia].
Topics: Animals; Bleomycin; Cell Cycle; Cell Survival; Cisplatin; Colony-Forming Units Assay; Cytarabine; Doxorubicin; Etoposide; Fluorouracil; Leukemia P388; Leukemia, Experimental; Melphalan; Mice; Peplomycin; Podophyllotoxin; Tumor Stem Cell Assay; Vinblastine | 1985 |
Verapamil potentiation of VP-16-213 in acute lymphatic leukemia and reversal of pleiotropic drug resistance.
Topics: Animals; Antineoplastic Agents; Cell Survival; Cells, Cultured; Daunorubicin; Dose-Response Relationship, Drug; Drug Resistance; Drug Synergism; Etoposide; Humans; Leukemia L1210; Leukemia P388; Leukemia, Experimental; Leukemia, Lymphoid; Mice; Podophyllotoxin; Verapamil; Vincristine | 1986 |
[Studies on the mechanism of multidrug resistance].
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Doxorubicin; Drug Resistance; Leukemia P388; Leukemia, Experimental; Mice; Naphthacenes; Podophyllotoxin; Quinacrine; Vinca Alkaloids; Vincristine | 1987 |
Studies in sugar chemistry. VII. Glucuronides of podophyllum derivatives.
Topics: Animals; Antineoplastic Agents, Phytogenic; Colonic Neoplasms; Drug Screening Assays, Antitumor; Glucuronates; Humans; Leukemia P388; Lung Neoplasms; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Plants, Medicinal; Plants, Toxic; Podophyllum; Tumor Cells, Cultured | 1997 |